SOF+DCV+SMV

DRUG2 trials

Sponsors

Humanity and Health Research Centre

Conditions

Chronic Hepatitis C Infection

Phase 2

Triple DAAs Regimen in Treating Non-cirrhotic HCV GT1b Subjects

CompletedNCT02470858

Humanity and Health Research CentreChronic Hepatitis C Infection

Start: 2015-01-31End: 2015-12-31Updated: 2016-03-01

Triple Combination DAAs for Treating HCV GT1b Subjects

WithdrawnNCT02932293

Humanity and Health Research CentreChronic Hepatitis C Infection

Start: 2016-12-31End: 2017-12-31Updated: 2017-05-12

Related Papers

Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.

2016-07-2570 citations